Chiara Scoccianti1, Béatrice Lauby-Secretan2, Pierre-Yves Bello3, Véronique Chajes1, Isabelle Romieu4. 1. Nutritional Epidemiology Group, International Agency for Research on Cancer, Lyon. 2. IARC Monographs Program Section, International Agency for Research on Cancer, Lyon. 3. Addictions Bureau, Health General Directorate, Paris, France. 4. Nutritional Epidemiology Group, International Agency for Research on Cancer, Lyon. Electronic address: romieui@iarc.fr.
Abstract
CONTEXT: Consumption of alcoholic beverages is one of the single most important known and modifiable risk factor for human cancer. Among women, breast cancer is the most common cancer worldwide and the leading cause of cancer-related mortality. Consumption of alcoholic beverages is causally associated with female breast cancer and the association shows a linear dose-response relationship. The role of heavy drinking has been long recognized and even a moderate intake is associated with an increased risk for breast cancer. The present review is an update of the current evidence on the association between alcohol consumption and breast cancer risk. The aim is to gain further insight into this association and to improve our current understanding of the effects of the major modifying factors. EVIDENCE ACQUISITION: Epidemiologic and experimental studies published since the most recent International Agency for Research on Cancer (IARC) Monograph on alcoholic beverages were identified in PubMed using a combination of keywords such as alcohol, breast cancer, polymorphisms, menopausal status. EVIDENCE SYNTHESIS: Cumulative lifetime consumption, drinking frequency, drinking patterns and timing of exposure each modulate the association between alcohol consumption and breast cancer. Hormonal status, genetic polymorphisms, and nutritional factors may interact with ethanol metabolism and further influence breast cancer risk. CONCLUSIONS: Better standardization among experimental and epidemiologic designs in assessing alcohol intake and timing of exposure may improve our understanding of the heterogeneity observed across studies, possibly allowing the quantification of the effects of occasional heavy drinking and the identification of a window of higher susceptibility to breast cancer development.
CONTEXT: Consumption of alcoholic beverages is one of the single most important known and modifiable risk factor for humancancer. Among women, breast cancer is the most common cancer worldwide and the leading cause of cancer-related mortality. Consumption of alcoholic beverages is causally associated with female breast cancer and the association shows a linear dose-response relationship. The role of heavy drinking has been long recognized and even a moderate intake is associated with an increased risk for breast cancer. The present review is an update of the current evidence on the association between alcohol consumption and breast cancer risk. The aim is to gain further insight into this association and to improve our current understanding of the effects of the major modifying factors. EVIDENCE ACQUISITION: Epidemiologic and experimental studies published since the most recent International Agency for Research on Cancer (IARC) Monograph on alcoholic beverages were identified in PubMed using a combination of keywords such as alcohol, breast cancer, polymorphisms, menopausal status. EVIDENCE SYNTHESIS: Cumulative lifetime consumption, drinking frequency, drinking patterns and timing of exposure each modulate the association between alcohol consumption and breast cancer. Hormonal status, genetic polymorphisms, and nutritional factors may interact with ethanol metabolism and further influence breast cancer risk. CONCLUSIONS: Better standardization among experimental and epidemiologic designs in assessing alcohol intake and timing of exposure may improve our understanding of the heterogeneity observed across studies, possibly allowing the quantification of the effects of occasional heavy drinking and the identification of a window of higher susceptibility to breast cancer development.
Authors: Nada Assi; Sabina Rinaldi; Vivian Viallon; S Ghazaleh Dashti; Laure Dossus; Agnès Fournier; Iris Cervenka; Marina Kvaskoff; Renée Turzanski-Fortner; Manuela Bergmann; Heiner Boeing; Salvatore Panico; Fulvio Ricceri; Domenico Palli; Rosario Tumino; Sara Grioni; María José Sánchez Pérez; María-Dolores Chirlaque; Catalina Bonet; Aurelio Barricarte Gurrea; Pilar Amiano Etxezarreta; Susana Merino; H Bas Bueno de Mesquita; Carla H van Gils; Charlotte Onland-Moret; Anne Tjønneland; Kim Overvad; Antonia Trichopoulou; Georgia Martimianaki; Anna Karakatsani; Tim Key; Sofia Christakoudi; Merete Ellingjord-Dale; Kostas Tsilidis; Elio Riboli; Rudolf Kaaks; Marc J Gunter; Pietro Ferrari Journal: Int J Cancer Date: 2019-04-30 Impact factor: 7.396
Authors: Lauren E Wilson; Zongli Xu; Sophia Harlid; Alexandra J White; Melissa A Troester; Dale P Sandler; Jack A Taylor Journal: Am J Epidemiol Date: 2019-06-01 Impact factor: 4.897
Authors: Fred K Tabung; Susan E Steck; Angela D Liese; Jiajia Zhang; Yunsheng Ma; Karen C Johnson; Dorothy S Lane; Lihong Qi; Linda Snetselaar; Mara Z Vitolins; Judith K Ockene; James R Hebert Journal: Breast Cancer Res Treat Date: 2016-07-30 Impact factor: 4.872
Authors: Amy M Berkman; Amy Trentham-Dietz; Kim Dittus; Vicki Hart; Christine M Vatovec; John G King; Ted A James; Susan G Lakoski; Brian L Sprague Journal: Prev Med Date: 2015-04-06 Impact factor: 4.018
Authors: Julia A Knight; Jing Fan; Kathleen E Malone; Esther M John; Charles F Lynch; Rikke Langballe; Leslie Bernstein; Roy E Shore; Jennifer D Brooks; Anne S Reiner; Meghan Woods; Xiaolin Liang; Jonine L Bernstein Journal: Int J Cancer Date: 2017-05-31 Impact factor: 7.396
Authors: Isabelle Romieu; Pietro Ferrari; Veronique Chajès; Jordi de Batlle; Carine Biessy; Chiara Scoccianti; Laure Dossus; Marie Christine Boutron; Nadia Bastide; Kim Overvad; Anja Olsen; Anne Tjønneland; Rudolf Kaaks; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Domenico Palli; Sabina Sieri; Rosario Tumino; Paolo Vineis; Salvatore Panico; H B As Bueno-de-Mesquita; Carla H Gils; Petra H Peeters; Eiliv Lund; Guri Skeie; Elisabete Weiderpass; J Ramón Quirós; María-Dolores Chirlaque; Eva Ardanaz; María-José Sánchez; Eric J Duell; Pilar Amiano Etxezarreta; Signe Borgquist; Göran Hallmans; Ingegerd Johansson; Lena Maria Nilsson; Kay-Tee Khaw; Nick Wareham; Timothy J Key; Ruth C Travis; Neil Murphy; Petra A Wark; Elio Riboli Journal: Int J Cancer Date: 2017-01-15 Impact factor: 7.396
Authors: Stephanie D Boone; Kathy B Baumgartner; Richard N Baumgartner; Avonne E Connor; Esther M John; Anna R Giuliano; Lisa M Hines; Shesh N Rai; Elizabeth C Riley; Christina M Pinkston; Roger K Wolff; Martha L Slattery Journal: Ann Epidemiol Date: 2015-08-28 Impact factor: 3.797
Authors: Dawn M Holman; Melissa Grossman; S Jane Henley; Lucy A Peipins; Laura Tison; Mary C White Journal: Am J Prev Med Date: 2014-03 Impact factor: 5.043